A compound of formula I:
or a pharmaceutically acceptable salt thereof, wherein R
1
and R
2
are each independently hydrogen or hydroxy; wherein R
1
and R
2
are not both hydroxy. Also provided are methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention and combinations thereof with other therapeutic agents.